ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,855, issued on Aug. 25, was assigned to SIRONAX LTD. (Grand Cayman, Cayman Islands).
"Ferroptosis inhibitors-diarylamine para-acetamides" was invented by Jianguang Han (Beijing) and Zhiyuan Zhang (Beijing).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are compounds that inhibit ferroptosis activity, or modulate or inhibit a disease associated with ferroptosis dysregulation, such as neuropathy, ischemia reperfusion injury, acute kidney failure and cancer, including corresponding sulfonamides, and pharmaceutically acceptable salts, hydrates and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of ma...